NONALCOHOLIC FATTY LIVER
Clinical trials for NONALCOHOLIC FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood donation may improve diabetes and fatty liver, study finds
Disease control CompletedThis study tested whether regularly removing blood (like donating blood) can lower iron levels and improve diabetes control and fatty liver disease. 132 adults aged 40-75 with prediabetes or diabetes took part. The treatment group gave blood several times, while the control group…
Matched conditions: NONALCOHOLIC FATTY LIVER
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Fatty liver drug shows promise in small trial
Disease control CompletedThis pilot study tested a drug called ibutamoren in 12 adults with nonalcoholic fatty liver disease (NAFLD). The goal was to see if it could lower fat in the liver. Participants took the drug for 6 months, and researchers measured liver fat using special MRI scans. The study was …
Matched conditions: NONALCOHOLIC FATTY LIVER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Massive study tracks fatty liver disease patients to uncover Real-World treatment patterns
Knowledge-focused CompletedThis study followed over 7,300 people with nonalcoholic fatty liver disease (NAFLD) and its more severe form, NASH, in regular doctor visits. Researchers aimed to understand how the disease progresses and what treatments doctors are using, since no drugs are officially approved f…
Matched conditions: NONALCOHOLIC FATTY LIVER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC